This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Delivery apps in South Korea receive KFTC examiners' reports as consent-decree efforts stall

By Jenny Lee ( October 13, 2025, 08:16 GMT | Insight) -- Baedal Minjok and Coupang Eats have entered the final stage of scrutiny by South Korea’s antitrust regulator, which on Monday sent formal examiners’ reports detailing alleged violations including “most-favored-nation” demands on restaurant partners and tying practices. The step follows the platforms’ earlier, but so far unsuccessful, bid to reach a consent decree due to a lack of concrete proposals.Baedal Minjok and Coupang Eats have entered the final stage of scrutiny by South Korea’s antitrust regulator, which on Monday sent formal examiners’ reports detailing alleged violations including “most-favored-nation” demands on restaurant partners and tying practices. The step follows the platforms’ earlier, but so far unsuccessful, bid to reach a consent decree due to a lack of concrete proposals....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections